Yield10 Bioscience, Inc. is contemplating filing for bankruptcy, as of November 14, 2023. According to company?s SEC filing, the company anticipate that their present capital resources will not be sufficient to fund its planned operations beyond early December 2023, which raises substantial doubt as to the Company's ability to continue as a going concern. It has recorded losses since its initial founding except in 2012.

The Company had an accumulated deficit of $410,886. As of September 30, 2023, it had restricted cash of $264, consisting of $229 held in connection with the lease agreement.